Investors Encouraged to Lead Class Action Against Metagenomi, Inc.
LOS ANGELES, Nov. 12, 2024 /PRNewswire/ — Glancy Prongay & Murray LLP (“GPM”) is calling upon investors who have suffered significant losses to participate in a securities fraud class action lawsuit against Metagenomi, Inc. (“Metagenomi” or the “Company”) MGX.
Class Period: February 2024 IPO
Lead Plaintiff Deadline: November 25, 2024
Investors interested in serving as a lead plaintiff in the Metagenomi lawsuit can submit their contact details at www.glancylaw.com/cases/Metagenomi-Inc/. For further information on their rights, reach out to Charles H. Linehan from GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com.
The complaint claims that during the Class Period, Defendants did not inform investors that: (1) Metagenomi’s partnership with Moderna was set to end immediately, and (2) consequently, Defendants’ positive comments about the Company’s operations and future prospects were misleading and not based on reasonable information.
For updates, follow us on LinkedIn, Twitter, or Facebook.
To join the class action, no immediate action is required. Individuals may choose to retain their own legal counsel or simply remain an absent class member. For more information on the class action, or if you have any questions about this announcement or your rights, please contact Charles Linehan, Esquire at GPM, located at 1925 Century Park East, Suite 2100, Los Angeles, California 90067, via 310-201-9150, Toll-Free at 888-773-9224, email at shareholders@glancylaw.com, or by visiting our website at www.glancylaw.com. When contacting via email, please provide your mailing address, phone number, and number of shares acquired.
This press release may qualify as Attorney Advertising in certain regions per applicable legal and ethical guidelines.
Contacts
Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com
View original content to download multimedia: here.
SOURCE Glancy Prongay & Murray LLP
Market News and Data brought to you by Benzinga APIs